bioRxiv Science⌕ Search

bioRxiv · 10.1101/2025.03.20.644344

Reassessing taxonomy and virulence in the Fusobacterium nucleatum group - Rebuttal of Fusobacterium animalis clades "Fna C1" and "Fna C2", genome announcement for Fusobacterium watanabei and description of Fusobacterium paranimalis sp. nov.

Abstract

There is a considerable interest in the association between Fusobacterium animalis and colorectal cancer (CRC). Recently, it was suggested that this association is valid only for a distinct clade of F. animalis (Fna C2) and that F. animalis strains belonging to another clade (Fna C1) are only associated with the oral cavity. It was further suggested that this made Fna C1 a natural comparator when looking for candidate genes associated with the pathogenicity of Fna C2. Based on such comparisons, three candidate operons enriched in CRC were suggested to explain the strong colorectal tumor association of F. animalis. In the present paper we show that major taxonomic errors invalidate the existence of two distinct clades of F. animalis and that Fna C1 is simply a rediscovery and misclassification of Fusobacterium watanabei. We further reassess the phylogenetic structure of the entire Fusobacterium nucleatum group encompassing F. animalis and all known closely related species and confirm the current taxonomy using contemporary phylogenetic principles. We also describe a novel Fusobacterium species more closely related to F. animalis than any other known species, for which we propose the name Fusobacterium paranimalis sp. nov.. We further searched for the three proposed candidate virulence operons of F. animalis across the entire F. nucleatum group and show that some or all of these are present in all other species except F. watanabei. We also observe considerable variability of Type 5 secretion systems (T5SS) by subtype and abundance across the F. nucleatum group. ImportanceIt is known that Fusobacterium animalis is able to survive within colorectal tumors. Recently, it was proposed that only one "clade" of Fusobacterium animalis could be found in colorectal tumors, and that another "clade" within the same species was instead only found in the oral cavity, and that differences in gene content could explain the habitat difference. We here show that these "clades" are two separate species by sequencing the type strain of the oral cavity-associated species, which is Fusobacterium watanabei. We also revisit other related species within the "Fusobacterium nucleatum group" to confirm that they are separate species, exemplified by presenting a new species, F. paranimalis sp.nov., which genetically is more related to F. animalis than any other known species including F. watanabei. We look at gene content of the entire group, and conclude that known virulence genes cannot fully explain F. animalis cancer association.

Source connections

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Sivertsen, A., Forni, D., Molteni, C., Bivand, J. M., Dimmen, G., Sironi, M., Kommedal, O.. 2025-03-24. Reassessing taxonomy and virulence in the Fusobacterium nucleatum group - Rebuttal of Fusobacterium animalis clades "Fna C1" and "Fna C2", genome announcement for Fusobacterium watanabei and description of Fusobacterium paranimalis sp. nov.. https://doi.org/10.1101/2025.03.20.644344

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Structural variation in repeat elements is widespread in normal human tissues and in tumorigenesis

Somatic mosaicism contributes to genomic variation, yet postzygotic structural variants remain under-characterized. We performed long- and short-read WGS from multiple individuals (n=47 normal tissues; n=168 samples) and identified mosaic structural variants in all individuals and germ layers, impacting a median 285.2 kb/genome. Nearly half of breakpoints were independently validated, with tissue distributions reflecting both early and late developmental origins. Most mosaic variants were repeat-mediated and 8.3% overlapped functional elements, an enrichment compared to germline variants. To extend these analyses in samples where long-read sequencing is infeasible, we measured repeat alterations from short-read sequencing, recapitulating mosaic tissue-specific differences. We characterized tumor- and tissue- specific variation in repeats across 15 cancer types and found tumor-related repeat variation to be similar in scale to that of normal mosaic variation. Tracking repeat changes in cell-free DNA provided a noninvasive approach for tumor monitoring. Our analyses revealed widespread repeat-driven structural variation in health and disease.

genomics↗

RNA isoform-resolved multiplexed sequencing with bioorthogonal barcoding

RNA isoform dysregulation drives disease pathogenesis and is the target of FDA-approved splice-switching therapeutics. However, multiplexed sequencing methods discard splice junction information because only 3' termini are barcoded and counted. Here, we repurpose acylation and click chemistries to conjugate bioorthogonal barcodes (bobcodes) directly onto multiple internal positions along cellular RNAs. Bobcoded RNAs from multiple samples are pooled for multiplexed cDNA synthesis, during which reverse transcriptase switches from each RNA template onto its tethered bobcode with greater than 99% accuracy in species mixing experiments. Bobcode attachment intervals set cDNA insert sizes without a library fragmentation step, and priming with poly(dT) or random hexamers selects between 3'-end counting and full-length isoform capture. A bioorthogonal barcode-sequencing (BOB-seq v0.1) drug screen identifies transcriptome-wide on- and off-target RNA splicing effects and outperforms existing multiplexing RNA sequencing methods in workflow simplicity, sample-to-sample variability, and barcoding accuracy. Bobcodes add isoform resolution to scalable multiplexed RNA sequencing.

genomics↗

Structural polymorphism and population-variable coding capacity of HERV-K(HML-2) in human pangenomes

Approximately 8% of the human genome is derived from ancient retroviral infections. The most recently integrated of these endogenous retroviruses is the HERV-K(HML-2) clade, whose expression has been associated with cancer, amyotrophic lateral sclerosis, and embryogenesis. Studies of HERV expression, particularly HML-2, have relied predominantly on short-read sequencing. However, the high similarity among HML-2 proviruses prevents many short reads from being assigned uniquely to individual loci. We therefore compared haplotype-resolved long-read genome assemblies from 292 donors to resolve variation in proviral structure and coding capacity. Several loci previously thought to be fixed were structurally polymorphic. Tandem arrays occurred at 13 loci and contained up to six proviral copies in a single array. At 8q11.23, we identified a previously undescribed full-length provirus in one haplotype. All 583 other haplotypes carried a solo-LTR. We found that standard reference genomes failed to represent the coding capacity retained in many individuals, whose proviruses contained intact open reading frames despite disruptive mutations in the reference sequences. Short-read genotypes left 32.5% of the tested donor-variant pairs unresolved at sites associated with viral reading frames. These findings show why HML-2 expression must be interpreted in the context of the structural and coding alleles each individual carries.

genomics↗